Dr Todd Eric Ogrodowczyk, MD in Morganton, NC - Medicare Pathology

Dr Todd Eric Ogrodowczyk, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Morganton, North Carolina. He went to University Of Tennessee, Hsc, College Of Medicine and graduated in 1999 and has 25 years of diverse experience with area of expertise as Pathology. He is a member of the group practice Blue Ridge Pathology Associates and his current practice location is 2201 S Sterling St, Morganton, North Carolina. You can reach out to his office (for appointments etc.) via phone at (828) 580-6111.

Dr Todd Eric Ogrodowczyk is licensed to practice in North Carolina (license number 2005-00507) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215990296.

Contact Information

	Dr Todd Eric Ogrodowczyk, MD
	2201 S Sterling St, Morganton, NC 28655-4044
	(828) 580-6111
	(828) 580-6109

Physician's Profile

Full Name	Dr Todd Eric Ogrodowczyk
Gender	Male
Speciality	Pathology
Experience	25 Years
Location	2201 S Sterling St, Morganton, North Carolina
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Todd Eric Ogrodowczyk attended and graduated from University Of Tennessee, Hsc, College Of Medicine in 1999

NPI Data:

NPI Number: 1215990296
Provider Enumeration Date: 04/10/2006
Last Update Date: 08/18/2010

Medicare PECOS Information:

PECOS PAC ID: 9931141702
Enrollment ID: I20050523001097

Medical Identifiers

Medical identifiers for Dr Todd Eric Ogrodowczyk such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215990296	NPI	-	NPPES
5900776	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	2005-00507 (North Carolina)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Carolinas Healthcare System-blue Ridge	Morganton, NC	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Blue Ridge Pathology Associates	2466447446	4

News Archive

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Do you currently take a vitamin D supplement? New research says you should. A study conducted by USANA Health Sciences, in conjunction with Intermountain Healthcare's The Orthopedic Specialty Hospital (TOSH), found that taking a daily vitamin D supplement is the best way to improve vitamin D levels in the body.

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Colorado auditors on Monday said that Children's Health Plan Plus, the state's version of SCHIP, incorrectly classified 10% of beneficiaries, the Denver Rocky Mountain News reports.

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

The Lancet Oncology has published results from the largest ever trial of a single melanoma treatment. The open label safety study was conducted to assess the tolerability of Zelboraf (vemurafenib), and featured 3,222 patients from across 44 countries.1 246 of these patients were from the UK.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Todd Eric Ogrodowczyk allows following entities to bill medicare on his behalf.

Entity Name	Blue Ridge Pathology Associates
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1568425262 PECOS PAC ID: 2466447446 Enrollment ID: O20040419000818

News Archive

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Colorado auditors on Monday said that Children's Health Plan Plus, the state's version of SCHIP, incorrectly classified 10% of beneficiaries, the Denver Rocky Mountain News reports.

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Todd Eric Ogrodowczyk is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Todd Eric Ogrodowczyk, MD Po Box 52990, Greenwood, SC 29649-0048 Ph: (864) 223-3600	Dr Todd Eric Ogrodowczyk, MD 2201 S Sterling St, Morganton, NC 28655-4044 Ph: (828) 580-6111

News Archive

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Colorado auditors on Monday said that Children's Health Plan Plus, the state's version of SCHIP, incorrectly classified 10% of beneficiaries, the Denver Rocky Mountain News reports.

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Pathology Doctors in Morganton, NC

Dr. J Hartley Bowen Iii, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2201 S Sterling St, Morganton, NC 28655 Phone: 828-580-6111 Fax: 828-580-6109
Dr. Andrew Robertson Brant, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2201 S Sterling St, Morganton, NC 28655 Phone: 828-580-6117 Fax: 828-580-6109
Dr. Dorwyn Wayne Croom Ii, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2201 S Sterling St, Morganton, NC 28655 Phone: 828-580-6117 Fax: 828-580-6109

Dr Todd Eric Ogrodowczyk, MD - Medicare Pathology in Morganton, NC

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Medicare Reassignments

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Taking daily vitamin D supplement is best way to improve vitamin D levels in the body

Colorado SCHIP classified 10% of beneficiaries incorrectly, according to state auditors

Study demonstrates efficacy, tolerability of vemurafenib in aggressive form of metastatic melanoma

Pathology Doctors in Morganton, NC